BLSM insider buying and SEC filings, explained
BlossomHill Therapeutics, Inc. · CIK 1839970
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$5.2M
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 10, 2026 | Other purchase | Carl L. Gordon (Director) bought 625,000 Common Stock indirectly at $16.00 ($10.0M) in a public offering. Indirect holdings up 30% to 2,714,279 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 12, 2026 |
| Aug 10, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director) bought 625,000 Common Stock indirectly at $16.00 ($10.0M) in a public offering. Indirect holdings up 30% to 2,714,279 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Aug 12, 2026 |
| Aug 10, 2026 | Purchase (code P) | John P. Schmid (Director) bought 6,000 shares at $16.00 ($96K), reported as a purchase (code P). New position of 6,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 7–10, 2026 | Purchase (code P) | Vincent Paul Liptak (General Counsel) bought 4,700 shares between Aug 7 and Aug 10 at about $15.89 ($75K), reported as a purchase (code P). Holdings up 4% to 111,412 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 10, 2026 | Purchase (code P) | Jason A Keyes (CFO) bought 700 shares at $16.00 ($11K), reported as a purchase (code P). New position of 700 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 10, 2026 | Purchase (code P) | Bihua Chen (Director and 10% owner) bought 312,500 shares indirectly at $16.00 ($5.0M), reported as a purchase (code P). Indirect holdings up 9% to 3,614,034 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Aug 10, 2026 |
10 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$5.2M in purchases since Aug 10, 2026 · Purchases traded Aug 10, 2026 to Aug 10, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Bihua Chen (Director) | $5.0M | Aug 10, 2026 | SEC filing |
| Jason A Keyes (CFO) | $11K | Aug 10, 2026 | SEC filing |
| Vincent Paul Liptak (General Counsel) | $75K | Aug 10, 2026 | SEC filing |
| John P. Schmid (Director) | $96K | Aug 10, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BLSM in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.